Chris Bosh could miss rest of season with blood clots on his lungs
Miami Heat forward Chris Bosh will undergo more tests on his lungs on Friday, and it is feared that he could have blood clots on his lungs that would cause him to miss the rest of the season, Joseph Goodman of the Miami Herald reports.
The Heat confirmed on Thursday that Bosh had been admitted to a local hospital to undergo testing. If blood clots are found on his lungs, Bosh will need to use blood thinners and will not be able to play this season.
Bosh was sent to the hospital after reporting for practice Thursday feeling "under the weather," according to head coach Erik Spoelstra.
The team didn't reveal the nature of the testing, but the Herald reported that initial tests focused on Bosh's lungs. A Heat spokesman said initial testing was inconclusive.
"In terms of all the rumors and speculation, we're aware of all the things that are out there,'' Spoelstra said, according to the Associated Press. ''Everybody's jumping the gun right now.
I know there's a lot out there.
"Frankly, there's not a full diagnosis right now. So for everybody to speculate, right now at this stage it's very premature," he added.
Bosh participated in the Shooting Stars event last Saturday during All-Star weekend and played 11 minutes in Sunday's All-Star Game, scoring 10 points.
It wasn't made clear if Bosh remained in the hospital as of Thursday night, but according to the Associated Press, the 30-year-old didn't travel with the team to New York for its second-half opener against the Knicks on Friday.
Heat assistant coach Juwan Howard said earlier this week that Bosh has been dealing with a rib injury in recent weeks but that it wasn't enough to prevent him from playing.
Bosh is averaging 21.1 points and seven rebounds per game this season. A free agent last offseason, he re-signed with Miami on a five-year, $118 million deal in July.
The news of Bosh's hospital admittance came the same day the Heat acquired point guard Goran Dragic from the Phoenix Suns shortly before the trade deadline.
No comments:
Post a Comment